Results 181 to 190 of about 114,692 (269)

Correction: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and cardiometabolic protection: historical development and future challenges. [PDF]

Cardiovasc Diabetol
Westermeier F, Fisman EZ.
europepmc   +1 more source

Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics. [PDF]

, 1975
Philip Raskin, Yoshikuni Fujita, Roger H. Unger   +2 more
openalex   +1 more source

Effects of Steroid Therapy on Pancreatic Endocrine Function in IgG4-related AIP: Evaluation by Arginine Stimulation Test. [PDF]

JCEM Case Rep
Matsushiro M, Haraguchi T, Yamazaki Y, Hamamoto Y, Seino Y.   +4 more
europepmc   +1 more source

Risk of acute kidney injury in dapagliflozin users with type 2 diabetes: A nationwide propensity score‐matched cohort study in Korea

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, EarlyView.
Abstract Background Several previous studies have identified a potential risk of acute kidney injury (AKI) associated with sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors, based on adverse event reports. However, recent European observational studies have shown conflicting results.
Hee‐Jin Kim, Heehyun Won, Suvin Park, Hui‐Eon Lee, Haerin Cho, Jeong Ah. Kim, Na‐Young Jeong, HoJin Shin, Ye‐Jee Kim, Nam‐Kyong Choi   +9 more
wiley   +1 more source

Investigating the impact of intestinal glucagon-like peptide-1 on hypoglycemia in type 1 diabetes. [PDF]

World J Diabetes
Nassar M, Gill AS, Marte E.
europepmc   +1 more source

The Effect of Intravenous Glucagon on Plasma Amino Acids in the Newborn [PDF]

, 1973
Salomon H. Reisner, Jacob V. Aranda, Eleanor Colle, Apostolos Papageorgiou, David Schiff, Charles R. Scriver, Leo Stern   +6 more
openalex   +1 more source

The neglected PCK1/glucagon (inter)action in nutrient homeostasis beyond gluconeogenesis: Disease pathogenesis and treatment. [PDF]

Mol Metab
Bertinat R, Holyoak T, Gatica R, Jara N, González-Chavarría I, Westermeier F.   +5 more
europepmc   +1 more source

Characterization of the Effects of Arginine and Glucose on Glucagon and Insulin Release from the Perfused Rat Pancreas [PDF]

, 1974
John E. Gerich, M. Arthur Charles, Gerold M. Grodsky   +2 more
openalex   +1 more source

Proteome of Renal Tubuli and Serum Differentiate Pre‐Existing Type 2 Diabetes and Post‐Transplant Diabetes in Kidney Transplant Recipients

PROTEOMICS – Clinical Applications, EarlyView.
ABSTRACT Purpose Diabetes mellitus (DM) is a major cause of end‐stage kidney disease (ESKD), with kidney transplantation being the preferred treatment. However, post‐transplant diabetes mellitus (PTDM) increases mortality and graft loss. While PTDM and Type 2 diabetes mellitus (T2DM) share risk factors, their mechanisms differ, particularly in diabetic
Eleni Skandalou, Mariell Rivedal, Hans‐Peter Marti, Thea A. S. Halden, Trond Jenssen, Bjørn Egil Vikse, Anders Åsberg, Jessica Furriol   +7 more
wiley   +1 more source

Regulation of LEAP2 by insulin and glucagon in mice and humans. [PDF]

Cell Rep Med
Johansen VBI, Gradel AKJ, Holm SK, Cuenco J, Merrild C, Petersen N, Demozay D, Mani BK, Suppli MP, Grøndahl MFG, Lund AB, Knop FK, Prada-Medina CA, Hogendorf WFJ, Lykkesfeldt J, Merkestein M, Sakamoto K, Holst B, Clemmensen C.   +18 more
europepmc   +1 more source